- Home
- APYX vs ANTX Comparison
APYX vs ANTX Comparison
Compare APYX & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APYX
- ANTX
- Stock Information
- Founded
- APYX 1982
- ANTX 2017
- Country
- APYX United States
- ANTX United States
- Employees
- APYX N/A
- ANTX N/A
- Industry
- APYX Medical/Dental Instruments
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- APYX Health Care
- ANTX Health Care
- Exchange
- APYX Nasdaq
- ANTX Nasdaq
- Market Cap
- APYX 42.3M
- ANTX 40.0M
- IPO Year
- APYX 1987
- ANTX 2022
- Fundamental
- Price
- APYX $1.59
- ANTX $1.32
- Analyst Decision
- APYX Hold
- ANTX Hold
- Analyst Count
- APYX 2
- ANTX 5
- Target Price
- APYX N/A
- ANTX $3.50
- AVG Volume (30 Days)
- APYX 68.5K
- ANTX 933.0K
- Earning Date
- APYX 11-08-2024
- ANTX 11-13-2024
- Dividend Yield
- APYX N/A
- ANTX N/A
- EPS Growth
- APYX N/A
- ANTX N/A
- EPS
- APYX N/A
- ANTX N/A
- Revenue
- APYX $48,542,000.00
- ANTX N/A
- Revenue This Year
- APYX N/A
- ANTX N/A
- Revenue Next Year
- APYX $2.78
- ANTX N/A
- P/E Ratio
- APYX N/A
- ANTX N/A
- Revenue Growth
- APYX N/A
- ANTX N/A
- 52 Week Low
- APYX $0.97
- ANTX $0.87
- 52 Week High
- APYX $2.80
- ANTX $22.22
- Technical
- Relative Strength Index (RSI)
- APYX 54.50
- ANTX 50.02
- Support Level
- APYX $1.52
- ANTX $1.32
- Resistance Level
- APYX $1.86
- ANTX $1.59
- Average True Range (ATR)
- APYX 0.22
- ANTX 0.09
- MACD
- APYX -0.01
- ANTX -0.03
- Stochastic Oscillator
- APYX 42.06
- ANTX 7.89
About APYX Apyx Medical Corporation
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease.